Adam Boruchov

1.4k total citations
22 papers, 929 citations indexed

About

Adam Boruchov is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Adam Boruchov has authored 22 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Adam Boruchov's work include Chronic Lymphocytic Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Acute Myeloid Leukemia Research (5 papers). Adam Boruchov is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Acute Myeloid Leukemia Research (5 papers). Adam Boruchov collaborates with scholars based in United States, France and Netherlands. Adam Boruchov's co-authors include James W. Young, Brigitte Sénéchal, Derek N.J. Hart, John L. Reagan, Pierre Fenaux, Hagop M. Kantarjian, Mikkael A. Sekeres, Kuolung Hu, Pamela S. Becker and Janet Franklin and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Adam Boruchov

22 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Boruchov United States	12	368	311	265	249	168	22	929
Willemijn B. Breunis Netherlands	17	434 1.2×	156 0.5×	94 0.4×	327 1.3×	316 1.9×	31	1.3k
Sophie Sibéril France	14	522 1.4×	149 0.5×	69 0.3×	232 0.9×	321 1.9×	31	930
Abhinav Deol United States	18	281 0.8×	631 2.0×	116 0.4×	294 1.2×	104 0.6×	114	1.1k
Paul G. Schlegel Germany	17	321 0.9×	219 0.7×	72 0.3×	154 0.6×	56 0.3×	38	764
Cristina João Portugal	14	205 0.6×	207 0.7×	114 0.4×	152 0.6×	68 0.4×	42	603
EF Winton United States	16	459 1.2×	323 1.0×	159 0.6×	200 0.8×	59 0.4×	32	1000
Otto Prümmer Germany	16	239 0.6×	141 0.5×	190 0.7×	89 0.4×	97 0.6×	42	798
Rajive Kumar India	19	163 0.4×	328 1.1×	151 0.6×	351 1.4×	32 0.2×	96	973
Olga Pozdnyakova United States	13	660 1.8×	188 0.6×	93 0.4×	96 0.4×	109 0.6×	28	944
Jürgen Enczmann Germany	20	454 1.2×	303 1.0×	92 0.3×	162 0.7×	145 0.9×	50	1.0k

Countries citing papers authored by Adam Boruchov

Since Specialization

Citations

This map shows the geographic impact of Adam Boruchov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Boruchov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Boruchov more than expected).

Fields of papers citing papers by Adam Boruchov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Boruchov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Boruchov. The network helps show where Adam Boruchov may publish in the future.

Co-authorship network of co-authors of Adam Boruchov

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Boruchov. A scholar is included among the top collaborators of Adam Boruchov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Boruchov. Adam Boruchov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davids, Matthew S., Haesook T. Kim, Alexandra Savell, et al.. (2018). Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study. The Lancet Haematology. 6(1). e38–e47. 90 indexed citations

Davids, Matthew S., Karen Francoeur, Hari P. Miskin, et al.. (2017). UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL. Hematological Oncology. 35(S2). 54–55. 6 indexed citations

Davids, Matthew S., Haesook T. Kim, Alexandra Savell, et al.. (2016). TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study. Blood. 128(22). 641–641. 15 indexed citations

Mehta–Shah, Neha, Matthew A. Lunning, Adam Boruchov, et al.. (2015). A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma.. Journal of Clinical Oncology. 33(15_suppl). 8521–8521. 25 indexed citations

Papanicolaou, Genovefa A., Yeon Joo Lee, James W. Young, et al.. (2015). Brincidofovir for Polyomavirus-Associated Nephropathy After Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Kidney Diseases. 65(5). 780–784. 44 indexed citations

Lunning, Matthew A., Jia Ruan, Adam Boruchov, et al.. (2014). A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results.. Journal of Clinical Oncology. 32(15_suppl). 8582–8582. 16 indexed citations

Papanicolaou, Genovefa A., James W. Young, Adam Boruchov, et al.. (2013). BK Virus-Associated Nephropathy (BKVN), an Under-Recognized Cause of Renal Dysfunction in Severely Immunosuppressed Hematopoietic Stem Cell Transplant (HSCT) Patients: Report of 5 Cases of Bkvn and the Potential Role of CMX001 for Treatment. Biology of Blood and Marrow Transplantation. 19(2). S302–S303. 3 indexed citations

Kourelis, Taxiarchis, Adam Boruchov, David Hull, et al.. (2012). Acute myeloid leukemia following solid organ transplantation: case report and comprehensive review.. PubMed. 76(3). 151–4. 5 indexed citations

Kourelis, Taxiarchis, et al.. (2011). Decitabine for Acute Myeloid Leukemia in a Patient Undergoing Hemodialysis. European Journal of Inflammation. 9(3). 289–292. 3 indexed citations

10.

Sekeres, Mikkael A., Hagop M. Kantarjian, Pierre Fenaux, et al.. (2010). Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. Cancer. 117(5). 992–1000. 54 indexed citations

11.

Boruchov, Adam. (2009). Thrombocytopenia in Myelodysplastic Syndromes and Myelofibrosis. Seminars in Hematology. 46(1 Suppl 2). S37–S43. 7 indexed citations

12.

Kantarjian, Hagop M., Pierre Fenaux, Mikkael A. Sekeres, et al.. (2009). Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia. Journal of Clinical Oncology. 28(3). 437–444. 126 indexed citations

13.

Sekeres, Mikkael A., H. Kantarjian, Pierre Fenaux, et al.. (2009). Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with myelodysplastic syndrome (MDS). Journal of Clinical Oncology. 27(15_suppl). 7009–7009. 3 indexed citations

14.

Zhou, Ping, Raymond L. Comenzo, Adam B. Olshen, et al.. (2008). CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy. Blood. 111(7). 3403–3406. 35 indexed citations

15.

Hassoun, Hani, Carlos D. Flombaum, Vivette D. D’Agati, et al.. (2008). High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease. Bone Marrow Transplantation. 42(6). 405–412. 38 indexed citations

16.

Landau, Heather, Hani Hassoun, Adam D. Cohen, et al.. (2008). Sequential Administration of Bortezomib, Liposomal Doxorubicin and Dexamethasone (BDD) Followed by Thalidomide and Dexamethasone (TD) Results in Rapid Control of Untreated High-Risk Multiple Myeloma (MM) and Improves Depth of Response. Blood. 112(11). 3712–3712. 2 indexed citations

17.

Kantarjian, Hagop M., Pierre Fenaux, Mikkael A. Sekeres, et al.. (2007). Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients (pts) with Low-Risk Myelodysplastic Syndrome (MDS): Update Including Extended Treatment.. Blood. 110(11). 250–250. 33 indexed citations

18.

Hassoun, Hani, Brian T. Rafferty, Carlos D. Flombaum, et al.. (2007). High Dose Chemotherapy and Autologous Stem Cell Transplantation with Melphalan in Patients with Monoclonal Immunoglobulin Deposition Disease Associated with Multiple Myeloma.. Blood. 110(11). 5113–5113. 1 indexed citations

19.

Boruchov, Adam. (2005). Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. Journal of Clinical Investigation. 115(10). 2914–2923. 283 indexed citations

20.

Sénéchal, Brigitte, Adam Boruchov, John L. Reagan, Derek N.J. Hart, & James W. Young. (2004). Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood. 103(11). 4207–4215. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact